Home/Hedge Fund Intelligence/Vir Biotechnology, Inc.
Nasdaq: VIRStockForm 13F30 Jun 2026

Hedge funds that hold Vir Biotechnology, Inc. Nasdaq: VIR

CUSIP 92764N102 · who reports it, how much, and how much it matters to them

22 of the 720 hedge fund managers we track reported shares of Vir Biotechnology, Inc. (Nasdaq: VIR) on Form 13F for 30 June 2026. Between them they reported USD 166m. The largest position belongs to POINT72 Asset Management, at USD 58m. The manager with the most riding on it is Superstring Capital Management, where it is 5.5% of the reported book.

Managers reporting it22of 720 we track
Value they reportUSD 166mshares only, 30 Jun 2026
Funds they run236with a file on PPLI.com
Largest positionUSD 58mPOINT72 Asset Management
Typical weight0.0%median share of a manager's book
Heaviest weight5.5%Superstring Capital Management

Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated

Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.

13F
What this page is

A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.

Who holds it

22 managers, USD 166m between them

Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.

Every manager that reports Vir Biotechnology, Inc., largest position first

The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.

#ManagerValue reportedShare of its book
1POINT72 Asset Management17 funds on PPLI.comUSD 58m0.1%
2Boxer Capital Management1 fund on PPLI.comUSD 19m1.4%
3Hudson Bay Capital Management8 funds on PPLI.comUSD 14m0.0%
4Two Sigma Investments35 funds on PPLI.comUSD 11m0.0%
5Sio Capital Management4 funds on PPLI.comUSD 11m1.8%
6Renaissance Technologies13 funds on PPLI.comUSD 10m0.0%
7Citadel Advisors32 funds on PPLI.comUSD 10m0.0%
8Superstring Capital Management1 fund on PPLI.comUSD 8.7m5.5%
9Weiss Asset Management5 funds on PPLI.comUSD 5.7m0.1%
10Walleye Capital8 funds on PPLI.comUSD 5.2m0.0%
11D. E. Shaw & Co.15 funds on PPLI.comUSD 4.2m0.0%
12Eversept Partners3 funds on PPLI.comUSD 1.6m0.1%
13Edgestream Partners5 funds on PPLI.comUSD 1.4m0.0%
14Engineers Gate Manager1 fund on PPLI.comUSD 1.3m0.0%
15Squarepoint Ops7 funds on PPLI.comUSD 1.3m0.0%
16Empyrean Capital Partners2 funds on PPLI.comUSD 1.2m0.0%
17Schonfeld Strategic Advisors30 funds on PPLI.comUSD 753,0000.0%
18LMR Partners2 funds on PPLI.comUSD 691,0000.0%
19Millennium Management6 funds on PPLI.comUSD 489,0000.0%
20Brevan Howard Capital Management39 funds on PPLI.comUSD 220,0000.0%
21The Quarry1 fund on PPLI.comUSD 4690.0%
22Summit Global Investments1 fund on PPLI.comUSD 3550.0%
Next: where it matters most
Where it matters most

For Superstring Capital Management it is 5.5% of the book

A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.

#ManagerValue reportedShare of its book
1Superstring Capital ManagementUSD 8.7m5.5%
2Sio Capital ManagementUSD 11m1.8%
3Boxer Capital ManagementUSD 19m1.4%
4Eversept PartnersUSD 1.6m0.1%
5POINT72 Asset ManagementUSD 58m0.1%
6Weiss Asset ManagementUSD 5.7m0.1%
7Edgestream PartnersUSD 1.4m0.0%
8Hudson Bay Capital ManagementUSD 14m0.0%
9Empyrean Capital PartnersUSD 1.2m0.0%
10Walleye CapitalUSD 5.2m0.0%
Next: how to read this
How to read this

What a 13F list can and cannot tell you

  • It is the manager's filing, not a fund's. Form 13F covers every account a firm runs. We cannot say which of its funds holds the shares.
  • It is a snapshot. The list shows the last day of the quarter. A manager may have bought or sold since, and trading inside the quarter leaves no trace.
  • It shows one side. Short positions, swaps and shares listed outside the United States are not reported, so a manager on this list may be hedged or net short.
  • It covers the managers we track. Our coverage is 720 managers of hedge and private funds. Banks, index funds and other institutions that file Form 13F are not counted here.
Next: questions
Questions

Questions about who holds Vir Biotechnology, Inc.

What is the ticker symbol of Vir Biotechnology, Inc.?

Vir Biotechnology, Inc. trades under the symbol VIR on the Nasdaq. Its CUSIP, the code used on Form 13F, is 92764N102.

Which hedge funds own Vir Biotechnology, Inc. (Nasdaq: VIR)?

22 of the 720 hedge fund managers PPLI.com tracks reported Vir Biotechnology, Inc. shares on Form 13F for 30 June 2026. The largest reported positions were held by POINT72 Asset Management (USD 58m), Boxer Capital Management (USD 19m), Hudson Bay Capital Management (USD 14m), Two Sigma Investments (USD 11m) and Sio Capital Management (USD 11m).

How many hedge funds hold Vir Biotechnology, Inc.?

22 managers in our coverage reported it, and between them they run 236 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.

Which manager has the most riding on Vir Biotechnology, Inc.?

Superstring Capital Management, where the position was 5.5% of the reported 13F book at 30 June 2026.

Does this show who is short Vir Biotechnology, Inc.?

No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.

Important information

Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Vir Biotechnology, Inc. or with the managers listed.

Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.

Private consultation →
Step 1 of 2

Tell us about yourself

Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.

✦Research assistant
✦PPLI.comResearch assistant
Explore PPLI questions and suitability factors
Ask a general question about PPLI, or explore the factors that affect suitability. Treat the answer as a starting point and check the linked sources.
Use the research with your own tax, legal and insurance advisers.
Preparing an answer
AI assistant. Educational information only. It does not determine eligibility or provide personal tax, legal, investment or insurance advice.